Abstract
Acquired hemophilia due to autoantibody to Factor VIII coagulant (Factor VIIIc) is a rare event which may be observed in patients with different autoimmune diseases. To our knowledge, this association has been reported only once in patients with autoimmune thyroid disease. Here we describe a patient presenting with a severe hemorrhagic disorder due to Factor VIIIc antibody in whom biochemical screening for thyroid diseases led to a diagnosis of hyperthyroid Graves’ disease not associated to overt clinical features. This case underlines the importance of carrying out a complete screening for autoimmunity, including thyroid autoimmune disease, in all patients with apparently isolated serum Factor VIIIc inhibitors.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aledort L. Inhibitors in hemophilia patients: current status and management. Am. J. Hematol. 1994, 47: 208–217.
Green D., Lechner K. A survey of 215 non-hemophilic patients with inhibitors to Factor VIII. Thromb. Haemost. 1981, 45: 200–203.
Volpe R. Autoimmune endocrinopathies: aspects of pathogenesis and the role of immune assays in investigation and management. Clin. Chem. 1994, 40: 2132–2145.
Ludgate M.E., Vassart G. The thyrotropin receptor as a model to illustrate receptor and receptor antibody diseases. Baillieres Clin. Endocrinol. Metab. 1995, 9: 95–113.
McIver B., Morris J.C. The pathogenesis of Graves’ disease. Endocrinol. Metab. Clin. North Am. 1998, 27: 73–89.
Weetman A.P., McGregor A.M. Autoimmune thyroid disease: further developments in our understanding. Endocr. Rev. 1994, 15: 788–830.
Sievert R., Goldstein M.L., Surks M.I. Graves’ disease and autoimmune factor VIII deficiency. Thyroid 1996, 6: 245–247.
Kasper C.K., Pool J.G. Letter: measurement of mild factor VIII inhibitors in Bethesda units. Thromb. Diath. Haemorrh. 1975, 34: 875–876.
Love P.E., Santoro S.A. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Ann. Intern. Med. 1990, 112: 682–698.
Marongiu F., Conti M., Murtas M.L., et al. Anticardiolipin antibodies in Graves’ disease: relationship with thrombin activity in vivo. Thromb Res. 1991, 64: 745–749.
Paggi A., Caccavo D., Ferri G.M., et al. Anti-cardiolipin antibodies in autoimmune thyroid diseases. Clin. Endocrinol. (Oxf.) 1994, 40: 329–333.
Nabriski D., Ellis M., Ness-Abramof R., et al. Autoimmune thyroid disease and antiphospholipid antibodies. Am. J. Hematol. 2000, 64: 73–75.
Woolf P.D. Transient painless thyroiditis with hyperthyroidism: a variant of lymphocytic thyroiditis? Endocr. Rev. 1980, 1: 411–420.
Felicetta J.V. Painful, painless, and postpartum thyroiditis. Distinct entities or merely variants? Postgrad. Med. 1989, 8: 269–272, 277.
Fradkin J.E., Wolff J. Iodine-induced thyrotoxicosis. Medicine (Baltimore) 1983, 62: 1–20.
Stanbury J.B., Ermans A.E., Bourdoux P., et al. Iodine-induced hyperthyroidism: occurrence and epidemiology. Thyroid 1998, 8: 83–100.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Marongiu, F., Cauli, C., Mameli, G. et al. Apathetic Graves’ disease and acquired hemophilia due to factor VIIIc antibody. J Endocrinol Invest 25, 246–249 (2002). https://doi.org/10.1007/BF03343998
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03343998